Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant - Pharmafile

Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant - Pharmafile

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofi’s consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately €10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant…

Opella launches as an independent company to redefine the future of self-care

Egypt, 5 May 2025 – It is official: Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of Opella, Sanofi keeping a significant shareholding with a 48.2% stake and Bpifrance owning a 1.8% stake. Opella is stepping into its next chapter with powerful backing, and a clear mission – “Health in Your Hands” – making self-care as simple as it should be. This is not just a change of ow…